Company Filing History:
1 out of 29 
1 out of 30 Years Active: 2010
Title: Hsiu-Li Song: Innovator in Monoclonal Antibody Development
Introduction
Hsiu-Li Song is a prominent inventor based in Taipei, Taiwan. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. Her innovative work has the potential to impact therapeutic approaches for various diseases.
Latest Patents
Hsiu-Li Song holds a patent for an Anti-VEGF monoclonal antibody. This invention provides novel monoclonal antibodies with a high binding affinity to all five isoforms of human VEGF. This advancement is crucial for developing treatments targeting vascular endothelial growth factor, which plays a significant role in various pathological conditions.
Career Highlights
Throughout her career, Hsiu-Li Song has worked with notable companies in the biotechnology sector. She has been associated with Taiwan Liposome Company, Ltd. and Tlc Biopharmaceuticals, Inc. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research.
Collaborations
Hsiu-Li Song has collaborated with esteemed colleagues, including Keelung Hong and Luke S S Guo. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Hsiu-Li Song is a trailblazer in the field of monoclonal antibody research. Her contributions, particularly in developing anti-VEGF antibodies, highlight her role as an influential inventor in biotechnology. Her work continues to pave the way for advancements in medical treatments.